Latuda (Lurasidone) Latuda (Lurasidone): Psychosis, Schizophrenia, Class of Drug, Side Effects, Mechanism of Action, DosageFrom:aohringerViews:15 1ratingsTime:06:23More inEducation The rest is here: Latuda (Lurasidone) - Video … Continue reading →

New York, NY (PRWEB) November 20, 2012 A report issued by the Institute for Safe Medicine Practices QuarterWatch (PDF) on October 3, 2012 estimates that prescription drug complaints to the FDA have risen 90% in the past 4 years, and two drugs, Pradaxa and Chantix, are responsible for 37% of that increase. Judge David Herndon, who is overseeing the ongoing Pradaxa bleeding litigation in a federal MDL Court, recently ordered that German drug maker Boehringer Ingelheim will have to provide access to its foreign witnesses and documents, according to a Case Management Order Regarding Foreign Defendants and Direct Filing signed on October 20, 2012. http://www.ilsd.uscourts.gov/opinions/ilsd_live.3.12.md.2385.2184887.0.pdf#search=%22pradaxa%22 The report comes as The Journal for The American Medical Association last month warned that the FDA may have rushed approval of Pradaxa, overlooking key Pradaxa side effects like internal bleeding. The FDA warned on December 7, 2011 that it was investigating Pradaxa after receiving more injury or death reports than expected. Anyone affected by internal bleeding after taking Pradaxa is urged to speak with a lawyer about their legal options as soon as possible. While all anticoagulants can cause internal bleeding, the Journal of Neurosurgery reported doctors concerns on March 6, 2012 that, once … Continue reading →

COLUMBUS, Ohio -- The Food and Drug Administration is taking a closer look at energy drinks to determine whether they are harmful to your health. The FDA is currently conducting an investigation into the possibility of a link between 13 deaths that occurred in the last four years and the 5-Hour Energy drink. The agency is also investigating five other deaths that could be linked to the Monster energy drinks. Some doctors say the high concentration of caffeine and similar ingredients in energy drinks can take a toll on a persons body, and it is difficult to measure how much of those ingredients a persons body can handle. Dr. Marchel Casavant says he has seen a number of patients who have had seizures after consuming these drinks. Weve gotten a number of calls, somewhere in the hundreds, from people complaining about the effects from these products. The makers of the 5-Hour Energy drink say the drink should be taken in moderation. Caffeine is not a bad thing, except in very large quantities. Its actually helpful in a lot of areas, said 5-Hour Energy Inventor Manjo Bhargava. Casavant says the drinks are similar to amphetamines. These are things that are not … Continue reading →

Dallas, TX (PRWEB) November 21, 2012 The latest financial report from German drugmaker Bayer made headlines as the company announced it would invest an additional $262 million to settle Yaz lawsuits. However, it may surprise more to note that the birth control drug still ranks among the top three most popular in sales despite more than 13,500 claims for blood clots.* The news comes as the American College of Obstetricians and Gynecologists last month renewed warnings that birth control pills containing drospirenone such as Yaz and Yasmin may have a higher risk of causing blood clots, according to the Chicago Tribune on October 24, 2012. In October of 2011, the FDA released a study entitled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" which found that drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%. Anyone who suffered a blood clot, DVT, stroke or Yaz Pulmonary Embolism after taking the drug is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options. Bayer confirmed in the latest report that it is settling claims involving blood clot injuries, such as deep vein … Continue reading →

New York, NY (PRWEB) November 20, 2012 A report issued by the Institute for Safe Medicine Practices QuarterWatch (PDF) on October 3, 2012 estimates that prescription drug complaints to the FDA have risen 90% in the past 4 years, and two drugs, Pradaxa and Chantix, are responsible for 37% of that increase. Experts have also recently warned of the safety of birth control products Yaz, Yasmin and NuvaRing. Last month, the American College of Obstetricians and Gynecologists renewed warnings that birth control pills containing drospirenone such as Yaz and Yasmin may have a higher risk of causing blood clots, according to the Chicago Tribune on October 24, 2012. On June 14, 2012, the New England Journal of Medicine also published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots over oral contraceptives. The Drug Risk Resource Center is committed to making prescription drug usage safer through public awareness of the latest research, safety warnings, FDA recalls and legal action. Already, legal action is underway in federal courts for patients who used Pradaxa, Yaz, Yasmin or NuvaRing and claim they were injured.* In addition, legal action over the IUD contraceptive Mirena is … Continue reading →

Dallas, TX (PRWEB) November 21, 2012 The latest report from the Judicial Panel on MultiDistrict Litigation indicates the number of Pradaxa cases filed in federal court over internal bleeding has risen, from approximately 100 to 151. The JPML issued its latest report on November 14, 2012.* The report comes as researchers disagree on the safety of the drug. The Journal for The American Medical Association warned on September 3, 2012 that the FDA may have rushed approval of Pradaxa, overlooking key Pradaxa side effects like internal bleeding. In its latest study released November 4, 2012, however, the FDA stated that, for now, Pradaxa carries the same risk as other blood thinners. A report issued by the Institute for Safe Medicine Practices QuarterWatch** on October 3, 2012 estimates that prescription drug complaints to the FDA have risen 90% in the past 4 years, and two drugs, Pradaxa and Chantix, are responsible for 37% of that increase. Anyone affected by internal bleeding after taking Pradaxa is urged to speak with a lawyer about their legal options as soon as possible. While all anticoagulants can cause internal bleeding, the Journal of Neurosurgery reported doctors concerns on March 6, 2012 that, once Pradaxa causes … Continue reading →

The Drug Risk Resource Center is the Webs premier source for information on drug and medical device research, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) November 21, 2012 However, the news comes as the FDA has received more than 45,000 adverse reports of complications among women using Mirena. The Adverse Events report on November 20, 2012 tracks the FDAs AERS reports through June 30, 2012. The most common Mirena side effects reported were device expulsion, device dislocation and vaginal hemorrhage, with more than 6% of patients requiring hospitalization or surgery. Anyone required to undergo surgery due to Mirena side effects is urged to speak with a lawyer about their legal options as soon as possible. The FDA has previously warned Bayer about the marketing of Mirena, which failed to disclose safety risks while claiming the devices could help busy moms with intimacy and make them look and feel great.* On November 11, 2012, Fox News reported that legal action over Mirena IUDs is on the horizon as Bayer faces growing claims that the device caused perforation, infection and hemorrhaging injuries.* Due to the number of Mirena lawsuits expected, Bayer recently petitioned that all cases be consolidated … Continue reading →